TY - JOUR
T1 - Implantable cardioverter-defibrillators
T2 - Expanding indications
AU - Naccarelli, Gerald V.
PY - 2004/7/1
Y1 - 2004/7/1
N2 - Purpose of review: This article reviews multiple secondary and primary prevention trials that have expanded the indications for implantable cardioverter-defibrillators (ICDs). Recent findings: Most studies performed over the last several years have concentrated on the role of ICDs in high-risk patients for the primary prevention of sudden death. Several recent trials that have been completed but not published are also reviewed. Summary: Data from recently completed trials and evolving ICD technology, such as ICDs with cardiac resynchronization capabilities, will alter indications for ICDs in the near future.
AB - Purpose of review: This article reviews multiple secondary and primary prevention trials that have expanded the indications for implantable cardioverter-defibrillators (ICDs). Recent findings: Most studies performed over the last several years have concentrated on the role of ICDs in high-risk patients for the primary prevention of sudden death. Several recent trials that have been completed but not published are also reviewed. Summary: Data from recently completed trials and evolving ICD technology, such as ICDs with cardiac resynchronization capabilities, will alter indications for ICDs in the near future.
UR - http://www.scopus.com/inward/record.url?scp=3142768385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3142768385&partnerID=8YFLogxK
U2 - 10.1097/01.hco.0000129666.57492.45
DO - 10.1097/01.hco.0000129666.57492.45
M3 - Review article
C2 - 15218389
AN - SCOPUS:3142768385
VL - 19
SP - 317
EP - 322
JO - Current Opinion in Cardiology
JF - Current Opinion in Cardiology
SN - 0268-4705
IS - 4
ER -